Summary
Background:
aging process is associated with changes in muscle mass and strength with decline of muscle strength after the 30th life year.
The aim of this study was to investigate these changes in muscle mass and strength.
Patients & Methods:
for this analysis 26 participants were subdivided in two groups. Group 1 comprises participants aged <40 years (n=14), group 2 those >40 years (n=12).
We assessed anthropometrics, range of motions, leg circumferences and isometric strength values of the knee joints.
Results:
besides comparable anthropometrics, circumferences and strength were higher in group 1 than in group 2. Circumference of upper leg (20 cm above knee articular space) showed for right leg a trend to a significant (median: 54.45 cm (1st quartile: 49.35/3rd quartile: 57.78) vs 49.80 cm (49.50/50.75), p=0.0526) and for left leg a significant 54.30 cm (49.28/58.13) vs 49.50 cm (48.00/52.53), p=0.0356) larger circumference in group 1. Isometric strength was in 60° knee flexion significantly higher in group 1 than in group 2 for right (729.88N (561.47/862.13) vs 456.92N (304.67/560.12), p=0.00448) and left leg (702.49N (581.36/983.87) vs 528.49N (332.95/648.58), p=0.0234).
Conclusions:
aging process leads to distinct muscle mass and strength loss. Muscle strength declines from people aged <40 years to those >40 years between 16.6% and 40.9%.
Keywords: muscle, strength, sarcopenia, isometric, age, aging
Background
Aging process is connected with widespread and typical changes in human body1–9. With increasing age body composition is changing3, 5, 10–12 with a loss of muscle mass and bone mass1–3, 5, 9–11, 13–15 and a reduction of physical capacity over years2, 8, 11, 16, 17.
Maximum of physical capacity is between 20th and 30th life years11. Pronounced changes with aging process take place after 50th life year2, 4, 11, 13, 15, 16. Profound changes with a leg lean body mass loss of 1–2%/year18–20 and a strength loss of 1.5–5%/year11,18–21 are reported for individuals older than 50 years (Tab. 1).
Table 1.
Strength loss with aging in literature.
Study | Leg lean muscle mass loss | Strength loss | Comments |
---|---|---|---|
Goodpaster et al.18 | Approximately 1%/year | 2.6–4.1%/year | Ethnic and sexspecific differences |
Frontera et al.19 | 1.3%/year | 1.7–2.5%/year | Longitudinal study over 12 years, starting age was in mean 65 life-years |
von Haehling et al.20 | 1–2%/year after 50th Life-year | 1.5% between ages 50 and 60 and by 3% thereafter | |
Zatsiorsky et al.11 | 1.5%/year between 50th and 70th lifeyear, 3%/year thereafter | ||
Doherty30 | 20–40% between 20th and 80th lifeyear | ||
Marcell et al.21 | 3.6–5%/year | Longitudinal study over approximately 5 years, starting age was 58.6±7.3 years | |
Proctor et al.16 | 35–40% between 20 and 80 years of age |
For those aged between 30 and 50 life-years published changes in muscle mass, power and strength are small4, 11, 16.
The aim of our study was to investigate changes in muscle mass and strength with the aging process and especially the comparison between people before and after 40th life year. We hypothesised that accelerated decline of strength and muscle mass loss starts already around 40th life-year.
Methods and patients
The study was designed to investigate the effects of aging on muscle mass and strength. 26 leg-healthy participants were examined at the orthopaedic University medical center of Frankfurt (Germany).
Patients were eligible for participation if they were at least 18 years old, not pregnant, did not had a congestive heart failure or an aortic valve stenosis, a neurological or rheumatological diseases, acute injuries of the knee joints, muscle diseases or muscle injuries of the legs. All participants gave informed consent.
For this analysis the participants were subdivided in two groups. Group 1 comprises the younger participants with age <40 years (n=14). Group 2 consists of the older participants with an age of 40 and older (40 + years) (n=12).
The participants were questioned about their medical history and we assessed anthropometric data of age, height and weight. The range of motion of the knee joints and the circumferences of the legs were measured.
We assessed the circumferences of both legs at the upper leg in 20 cm and 10 cm above the articular space of the knee joint and at the lower leg in 10 cm beyond the articular space of the knee joint and the largest circumference of the lower leg.
Moreover we measured the maximum isometric strength of extension movements in the knee joints of the participants in a sitting position with a strength measuring system (Dynamometer BIODEX® System 3) in 30° and 60° flexion of the knee joint. The torque was measured and assessed by the software Myoresearch 98 (Version 1, Noraxon, Phoenix Arzona). The length of the lever arm was used to calculate the isometric strength values of both legs. We assessed an average 3 sec maximum strength value of a maximum isometric muscle contraction of an extension movement of the leg over 5 sec.
The two groups were compared for anthropometric characteristics, circumference parameters of the legs, range of motion values and strength parameters.
Statistic tests
The computerized analysis of the data was done with the statistic software system BIAS® Version 9.12. We used the Wilcoxon-Mann-Whitney-test to detect differences between the groups. In the text values are presented as median with 1st and 3rd quartile. The threshold for significance was set to a p-value of 0.05.
Results
We examined 26 leg-healthy participants at the orthopaedic University medical center of Frankfurt (Germany).
The participants of group 1 were 31 years (1st quartile: 27.75/3rd quartile: 36.50) old in median. The median age of group 2 was 54 years (43.50/61.00). The groups were similar in the anthropometric data. Also the parameters of range of motion were comparable between the groups. The characteristics of the groups are shown in Table 2.
Table 2.
Characteristics with regards to anthropometric values and range of motion of the knee joints of the two groups. Data were presented as mean values with standard deviation and p-values for difference.
Group 1 (<40 years) | Group 2 (40+ years) | P value | |
---|---|---|---|
Number | 14 | 12 | |
Age | 31.43±5.37 years | 52.42±8.41 years | |
Height | 173.64±11.03 cm | 170.00±7.85 cm | p = 0.527 |
Weight | 73.36±13.49 kg | 72.67±9.42 kg | p = 1.000 |
Body mass index | 24.26±3.51 kg/m2 | 25.05±1.68 kg/m2 | p = 0.322 |
Range of motion | |||
Straightening right knee | −0.71±1.64 ° | −0.17±0.58 ° | p = 0.595 |
Straightening left knee | −0.86±1.99 ° | −0.17±0.58 ° | p = 0.595 |
Flexion right knee | 139.36±5.81 ° | 135.92±4.10 ° | p = 0.131 |
Flexion left knee | 140.60±6.58 ° | 137.70±3.87 ° | p = 0.252 |
The median circumference values were in all measurements larger in group 1 than in group 2 (Tab. 3). The circumference values of the upper leg in 20 cm above the articular space of the knee joint showed for the right leg a trend to a significant 54.45 cm (49.35/57.78) vs 49.80 cm (49.50/50.75), p=0.0526) and for the left leg a significant 54.30 cm (49.28/58.13) vs 49.50 cm (48.00/52.53), p=0.0356) larger circumference in the younger participants (group 1).
Table 3.
Circumferences of the legs and isometric strength values of the two groups. Data were presented as mean values with standard deviation and p-values for difference.
Circumference | Group <40 years | Group 40+ years | P value | |
---|---|---|---|---|
Upper leg in 20cm above the articular | Right leg | 54.03±4.55 cm | 49.98±2.50 cm | p=0.0526 |
space of the knee joint | Left leg | 53.87±4.69 cm | 49.98±2.70 cm | p=0.0356 |
Upper leg in 10cm above the articular | Right leg | 45.39±3.41 cm | 43.36±1.90 cm | p=0.0757 |
space of the knee joint | Left leg | 45.24±3.79 cm | 42.54±2.32 cm | p=0.0673 |
Lower leg in 10cm beyond the articular | Right leg | 37.32±3.16 cm | 35.08±2.56 cm | p=0.0673 |
space of the knee joint | Left leg | 36.73±3.19 cm | 35.18±1.96 cm | p=0.0950 |
Largest circumference of the lower leg | Right leg | 38.61±3.27 cm | 36.70±2.76 cm | p=0.106 |
Left leg | 38.30±3.27 cm | 36.71±2.67 cm | p=0.212 | |
Isometric maximum strength in 60° | Right leg | 716.96±291.88 N | 423.84±179.45 N | p=0.00448 |
knee flexion | Left leg | 757.55±291.08 N | 520.97±220.25 N | p=0.0234 |
Isometric maximum strength in 30° | Right leg | 389.37±110.50 N | 324.91±117.22 N | p=0.252 |
knee flexion | Left leg | 423.91±137.26 N | 309.03±135.79 N | p=0.0596 |
Also the circumference of the upper leg in 10 cm above and of the lower leg 10 cm beyond the articular space of the knee joint showed for both legs a trend to a significant larger circumference in the younger participants (group 1).
The isometric strength was in 60° knee flexion significantly higher in group 1 than in group 2 for the right leg (729.88N (561.47/862.13) vs 456.92N (304.67/560.12), p=0.00448) (Tab. 3) (Fig. 1) as well as for the left leg (702.49N (581.36/983.87) vs 528.49N (332.95/648.58), p=0.0234) (Tab. 3) (Fig. 2). In 30° flexion the mean strength values of group 1 were higher than these of group 2, but the difference between the groups was not significant (Tab. 3).
Figure 1.
Maximum isometric strength of the right leg in 60° flexion of both groups.
Figure 2.
Maximum isometric strength of the left leg in 60° flexion of both groups.
Discussion
The muscular system accounts approximately 40% of the total body mass and human body’s cell mass consists in 75% of muscle cells22. Approximately a quarter of the total body protein synthesis takes place in the muscular system22. Skeletal muscle is an important tissue of the human body23, which is especially responsible for voluntary movement control24. Aging process leads to a decrease in muscle mass and strength9, 16, 22, 25. Loss of strength is directly connected with reduction of muscle mass2, 11.
The maximum of physical capacity comprises the decade between 20th and 30th life year11. Between 30th to 50th life year the reported changes in muscle mass, power and strength are small4, 11, 16. Pronounced changes with aging process occur after 50th life year with more than 15% strength loss per decade2, 4, 11, 13, 15, 16, 20, 26.
In accordance with literature the results of our study confirm that aging leads to a distinct muscle mass and strength loss. But in contrast to literature the results of our study show a larger strength decline as described in literature for the middle aged persons between 40th and 60th life years. The difference between the median age of group 1 and 2 was more than 20 years (31 years vs 54 years). The decreases of the mean strength in these 2 decades were between 16.6% and 27.1% in 30° knee flexion and between 31.2% and 40.9% in 60° knee flexion. Therefore was the mean strength loss in these 2 decades in contrast to literature larger than estimated. These results support the hypothesis that the accelerated process of muscle mass and strength loss starts earlier nearby the 40th life year.
The pathophysiology of strength and muscle mass loss with aging process is complex27. Muscle mass loss is caused by reduced numbers of muscle fibers and motor units and decline of muscle fiber size2, 11,27–30. If muscle fibers deceed a critical minimal size, apoptosis begins11. Other causes of apoptosis with aging process are denervation and loss of neurons4, 11, 31. Moreover strength capacities per motor unit decrease22. Loss of muscle fibers reduces strength capacities, decreases muscle metabolism and increase risk of muscle damage11. Synthesis rate of muscle protein decreases with aging process6, 14, 16, 17, 22, 28, 30, 32. Moreover muscle repair capacities are reduced with increased age33.
Atrophy of muscle fibers is disproportionally distributed with higher atrophy rate of type IIa fast twitch (FT) muscle fibers and their motor units17, 22, 30. FT muscle fibers seem to be more prone to a function failure or a function loss over time and therefore are primarily affected bei muscle fiber loss related to aging process4, 11, 28, 32. In the timeframe between 20th and 75th life year more than 50% of FT muscle fibers get lost11.
One major cause of strength and muscle mass loss with aging process is the decline of anabolic hormones, which results in a katabolic effect on muscles and bones4, 11, 15–17, 22, 25, 30. The reduced hormone levels of testosterone, dehydroepiandrosterone, growth hormone, and insulin-like growth factor-I play a main role in this process4, 15–17, 22. About the 50th life year hormonal status of human body is changing11, 25. In men andropause takes place in this time period11. The menopause of women begins between 45th and 55th life year11. The decline of hormonal synthesis leads to distinct changes in human body with decreasing muscle mass and strength11, 25, 30.
Besides the loss of anabolic factors such as neural growth factors, growth hormone, androgens and estrogens, and physical inactivity an increase of catabolic factors such as inflammatory cytokines could contribute to muscle mass and strength loss4, 22, 30. Especially interleukin-1β, tumor necrosis factor (TNF)-α, and interleukin-6 support a decrease the muscle mass4, 22, 27, 30.
Co-morbidities like malignancy, chronic obstructive pulmonary disease, congestive heart failure, inflammatory bowel disease and rheumatoid arthritis also contribute to muscle mass und strength loss with aging process34–38. Other diseases with a period of disability like deep vein thrombosis, pulmonary embolism, myocardial infarction, pneumonia or surgeries keep also the risk for strength and muscle mass loss in elderly39, 40.
The decrease in physical activity with aging process is the key factor in development of strength and muscle mass loss17, 22, 30, 41. Physical inactivity leads to muscle atrophy30. Loss of appetite is an additive problem in older adults as insufficient nutrient intake that can also contribute to muscle loss17. Therefore one of the great challenges of aging process is to decline muscle mass loss and loss of strength11, 22. Strength training is one important tool to counteract this problem2, 11, 22.
Besides the physiological loss of strength and muscle mass, sarcopenia is a syndrome characterised by progressive and generalised loss of skeletal muscle strength and mass in elderly4–8, 22, 27, 28, 30, 32, 34. Sarcopenia is connected with physical disability, poor quality of life and death34. The criteria of the European consensus on the definition of sarcopenia comprise low muscle mass, low muscle strength and low physical performance34. The diagnosis of sarcopenia could be made if a low muscle mass consists and at least one of the two other criteria are also existing34.
Limitations
There were some limitations of this study. At first only a small number of leg-healthy participants was included in this study. It would be of further interest to have a large number of participants of every decade of life to compare the individuals of the several decades about the muscle mass and strength loss. Moreover further studies should investigate the influence of diseases on the skeletal muscle system with its typical changes with aging process.
Conclusions
Aging process leads to a distinct muscle mass and strength loss. The decline of the muscle strength of people, who were younger than 40 years, in comparison to those, who were older than 40 years was ranged between 16.6% and 40.9%.
Footnotes
Conflicts of interest
Karsten Keller declares that he has no conflict of interest. Martin Engelhardt declares that he has no conflict of interest.
The Study was done at the Department of Orthopedics, University Hospital Frankfurt, Germany
References
- 1.Ferris LT, Williams JS, Shen CL, O'Keefe KA, Hale KB. Resistance training improves sleep quality in older adults – a pilot study. Journal of Sports Science and Medicine. 2005;4:354–360. [PMC free article] [PubMed] [Google Scholar]
- 2.Surakka J. Power-type strength training in middle-aged men and women. Journal of Sports Science and Medicine. 2005;Supplement 9:1–35. [Google Scholar]
- 3.Palmer IJ, Runnels ED, Bemben MG, Bemben DA. Muscle-bone interactions across age in men. Journal of Sport Science and Medicine. 2006;5:43–51. [PMC free article] [PubMed] [Google Scholar]
- 4.Deschenes MR. Effects of aging on muscle fibre type and size. Sports Med. 2004;34:809–824. doi: 10.2165/00007256-200434120-00002. [DOI] [PubMed] [Google Scholar]
- 5.Evans WJ. What is sarcopenia? The journals of gerontology. Series A, Biological sciences and medical sciences. 1995;50(Spec No 5–8) doi: 10.1093/gerona/50a.special_issue.5. [DOI] [PubMed] [Google Scholar]
- 6.Evans WJ, Campbell WW. Sarcopenia and age-related changes in body composition and functional capacity. The Journal of nutrition. 1993;123:465–468. doi: 10.1093/jn/123.suppl_2.465. [DOI] [PubMed] [Google Scholar]
- 7.Gallagher D, Ruts E, Visser M, et al. Weight stability masks sarcopenia in elderly men and women. American journal of physiology. Endocrinology and metabolism. 2000;279:E366–375. doi: 10.1152/ajpendo.2000.279.2.E366. [DOI] [PubMed] [Google Scholar]
- 8.Morrison S, Newell KM. Aging, neuromuscular decline, and the change in physiological and behavioral complexity of upper-limb movement dynamics. Journal of aging research. 2012;2012:891218. doi: 10.1155/2012/891218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Harbo T, Brincks J, Andersen H. Maximal isokinetic and isometric muscle strength of major muscle groups related to age, body mass, height, and sex in 178 healthy subjects. European journal of applied physiology. 2012;112:267–275. doi: 10.1007/s00421-011-1975-3. [DOI] [PubMed] [Google Scholar]
- 10.McCurdy K, Langford G. The relationship between maximum unilateral squat strength and balance in young adult men and women. Journal of Sports Science and Medicine. 2006;5:282–288. [PMC free article] [PubMed] [Google Scholar]
- 11.Zatsiorsky VM, Kreamer WJ. Krafttraining in praxis und wissenschaft. Aachen: Meyer & Meyer Verlag; 2008. [Google Scholar]
- 12.Vaillancourt DE, Newell KM. Aging and the time and frequency structure of force output variability. J Appl Physiol. 2003;94:903–912. doi: 10.1152/japplphysiol.00166.2002. [DOI] [PubMed] [Google Scholar]
- 13.Doherty TJ. The influence of aging and sex on skeletal muscle mass and strength. Current opinion in clinical nutrition and metabolic care. 2001;4:503–508. doi: 10.1097/00075197-200111000-00007. [DOI] [PubMed] [Google Scholar]
- 14.Prochniewicz E, Thompson LV, Thomas DD. Age-related decline in actomyosin structure and function. Experimental gerontology. 2007;42:931–938. doi: 10.1016/j.exger.2007.06.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mechanisms of ageing and development. 1999;107:123–136. doi: 10.1016/s0047-6374(98)00130-4. [DOI] [PubMed] [Google Scholar]
- 16.Proctor DN, Balagopal P, Nair KS. Age-related sarcopenia in humans is associated with reduced synthetic rates of specific muscle proteins. The Journal of nutrition. 1998;128:351S–355S. doi: 10.1093/jn/128.2.351S. [DOI] [PubMed] [Google Scholar]
- 17.Jones TE, Stephenson KW, King JG, Knight KR, Marshall TL, Scott WB. Sarcopenia--mechanisms and treatments. J Geriatr Phys Ther. 2009;32:83–89. [PubMed] [Google Scholar]
- 18.Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: The health, aging and body composition study. The journals of gerontology. Series A, Biological sciences and medical sciences. 2006;61:1059–1064. doi: 10.1093/gerona/61.10.1059. [DOI] [PubMed] [Google Scholar]
- 19.Frontera WR, Hughes VA, Fielding RA, Fiatarone MA, Evans WJ, Roubenoff R. Aging of skeletal muscle: A 12-yr longitudinal study. J Appl Physiol. 2000;88:1321–1326. doi: 10.1152/jappl.2000.88.4.1321. [DOI] [PubMed] [Google Scholar]
- 20.von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: Facts and numbers on prevalence and clinical impact. J Cachex Sarcopenia Muscle. 2010;1:129–133. doi: 10.1007/s13539-010-0014-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Marcell TJ, Hawkins SA, Wiswell RA. Leg strength declines with advancing age despite habitual endurance exercise in active older adults. Journal of strength and conditioning research/National Strength & Conditioning Association. 2013. [DOI] [PubMed]
- 22.Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. The Journal of laboratory and clinical medicine. 2001;137:231–243. doi: 10.1067/mlc.2001.113504. [DOI] [PubMed] [Google Scholar]
- 23.Longwei X. Clinical application of diffusion tensor magnetic resonance imaging in skeletal muscle. Muscles, ligaments and tendons journal. 2012;2:19–24. [PMC free article] [PubMed] [Google Scholar]
- 24.Rizzi R, Bearzi C, Mauretti A, Bernardini S, Cannata S, Gargioli C. Tissue engineering for skeletal muscle regeneration. Muscles, ligaments and tendons journal. 2012;2:230–234. [PMC free article] [PubMed] [Google Scholar]
- 25.Vermeulen A, Goemaere S, Kaufman JM. Testosterone, body composition and aging. Journal of endocrinological investigation. 1999;22:110–116. [PubMed] [Google Scholar]
- 26.Buonocore D, Rucci S, Vandoni M, Negro M, Marzatico F. Oxidative system in aged skeletal muscle. Muscles, ligaments and tendons journal. 2011;1:85–90. [PMC free article] [PubMed] [Google Scholar]
- 27.Bauer JM, Kaiser MJ, Sieber CC. Sarcopenia in nursing home residents. Journal of the American Medical Directors Association. 2008;9:545–551. doi: 10.1016/j.jamda.2008.04.010. [DOI] [PubMed] [Google Scholar]
- 28.Thompson LV. Age-related muscle dysfunction. Experimental gerontology. 2009;44:106–111. doi: 10.1016/j.exger.2008.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Klein CS, Rice CL, Marsh GD. Normalized force, activation, and coactivation in the arm muscles of young and old men. J Appl Physiol. 2001;91:1341–1349. doi: 10.1152/jappl.2001.91.3.1341. [DOI] [PubMed] [Google Scholar]
- 30.Doherty TJ. Invited review: Aging and sarcopenia. J Appl Physiol. 2003;95:1717–1727. doi: 10.1152/japplphysiol.00347.2003. [DOI] [PubMed] [Google Scholar]
- 31.Özkaya GY, Aydin H, Toraman FN, Kizilay F, Ozdemir Ö, Cetinkaya V. Effect of strength and endurance training on cognition in older people. Journal of Sport Science and Medicine. 2005;4:300–313. [PMC free article] [PubMed] [Google Scholar]
- 32.Lin J, Lopez EF, Jin Y, Van Remmen H, Bauch T, Han HC, Lindsey ML. Age-related cardiac muscle sarcopenia: Combining experimental and mathematical modeling to identify mechanisms. Experimental gerontology. 2008;43:296–306. doi: 10.1016/j.exger.2007.12.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Raggi C, Berardi AC. Mesenchymal stem cells, aging and regenerative medicine. Muscles, ligaments and tendons journal. 2012;2:239–242. [PMC free article] [PubMed] [Google Scholar]
- 34.Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. European consensus on definition and diagnosis: Report of the european working group on sarcopenia in older people. Age and ageing. 2010;39:412–423. doi: 10.1093/ageing/afq034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Higgens CS, Keighley MR, Allan RN. Impact of preoperative weight loss and body composition changes on postoperative outcome in surgery for inflammatory bowel disease. Gut. 1984;25:732–736. doi: 10.1136/gut.25.7.732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Rocha R, Santana GO, Almeida N, Lyra AC. Analysis of fat and muscle mass in patients with inflammatory bowel disease during remission and active phase. The British journal of nutrition. 2009;101:676–679. doi: 10.1017/S0007114508032224. [DOI] [PubMed] [Google Scholar]
- 37.Nishimura Y, Tsutsumi M, Nakata H, Tsunenari T, Maeda H, Yokoyama M. Relationship between respiratory muscle strength and lean body mass in men with copd. Chest. 1995;107:1232–1236. doi: 10.1378/chest.107.5.1232. [DOI] [PubMed] [Google Scholar]
- 38.Evans WJ. Skeletal muscle loss: Cachexia, sarcopenia, and inactivity. The American journal of clinical nutrition. 2010;91:1123S–1127S. doi: 10.3945/ajcn.2010.28608A. [DOI] [PubMed] [Google Scholar]
- 39.Keller K, Engelhardt M. Sportverletzung Sportschaden: Organ der Gesellschaft fur Orthopädisch-Traumatologische Sportmedizin. 2013;27:91–95. doi: 10.1055/s-0033-1335159. [muscle atrophy caused by limited mobilisation] [DOI] [PubMed] [Google Scholar]
- 40.Windsor JA, Hill GL. Weight loss with physiologic impairment. A basic indicator of surgical risk. Annals of surgery. 1988;207:290–296. doi: 10.1097/00000658-198803000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Dittmer DK, Teasell R. Complications of immobilization and bed rest. Part 1: Musculoskeletal and cardiovascular complications. Canadian family physician Medecin de famille canadien. 1993;39:1428–1432. [PMC free article] [PubMed] [Google Scholar]